NCT02076971View on ClinicalTrials.gov

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Cytomegalovirus Infections

Trial Locations (7)

14004

Hospital Universitario Reina Sofía, Córdoba

15006

Hospital Universitario A Coruña, A Coruña

28041

Hospital Universitario 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

39008

Hospital Universitario Marqués de Valdecilla, Santander

46026

Hospital Universitario y Politécnico la Fe, Valencia

08035

Hospital Vall d'Hebrón, Barcelona

All Listed Sponsors

collaborator

Roche Farma, S.A

INDUSTRY

lead

Fundacio Catalana de Pneumologia

OTHER

NCT02076971 - Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive | Biotech Hunter | Biotech Hunter